[["MCT8 (SLC16A2)", "has", "a pivotal role in neuronal triiodothyronine (T(3)) uptake"], ["mutations of MCT8", "determine", "a distinct X-linked psychomotor retardation syndrome (AHDS)"], ["AHDS", "is attributed to", "disturbed thyroid hormone levels"], ["disturbed thyroid hormone levels", "especially include", "elevated T(3) levels"], ["the genetic analysis of the MCT8 gene", "was described in", "a patient suspected for AHDS"], ["L-thyroxine (LT(4)) or liothyronine (LT(3)) treatment", "intends to overcome", "the T(3) uptake resistance through alternative transporters"], ["the six exons of the MCT8 gene", "were amplified", "individually by PCR"], ["the length of the X-chromosomal deletion", "was determined by", "a dense SNP array"], ["PCR-based fine mapping", "was used to define", "the exact borders of the deleted segment"], ["the clinical and endocrine data of the patient", "were evaluated during", "6.5 years of LT(4) treatment"], ["the clinical and endocrine data of the patient", "were evaluated during", "two periods of low- and high-dose LT(3)"], ["a partial deletion of the MCT8 gene", "was detected", "confirming the suspected AHDS"], ["MCT8 dysfunction", "was associated with", "partial resistance to T(3) at the hypothalamus and pituitary level"], ["MCT8 dysfunction", "was associated with", "normal responsiveness at the peripheral organs"], ["thyroid hormone administration", "had", "no beneficial effect on the neurological status of the patient"], ["a 70 kb deletion", "encompassed", "exons 2-6 of the MCT8 gene"], ["both LT(4) and LT(3) administration", "had", "no therapeutic effect"], ["treatment of AHDS patients", "with thyroid hormone analogs", "should be considered"]]